BQ vs POM
Boqii Holding Ltd. and Pomdoctor Ltd., side by side — 3 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BQ | POM |
|---|---|---|
| Revenue | CNY 420.5M | CNY 399.9M |
| Net income | CNY -5.1M | CNY -130.9M |
| Gross margin | 26.3% | 13.1% |
| Net margin | −0.4% | −32.7% |
| Return on equity | −2.7% | — |
| Diluted EPS | −CNY 1.47 | −CNY 21.96 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | CNY -30.4M | CNY -149.5M |
| Equity | CNY 188.0M | CNY -454.0M |
| Net debt / equity | −0.09× | — |
| Current ratio | 3.25× | 0.48× |
| Revenue CAGR 5y | −16.1% | — |
| Profit CAGR 5y | — | — |
BQ and POM book revenue within 15% of each other, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
3 years side by side
| Fiscal year | BQ | POM |
|---|---|---|
| FY2025 | CNY 420.5M | CNY 399.9M |
| FY2024 | CNY 468.9M | CNY 342.6M |
| FY2023 | CNY 709.4M | CNY 304.9M |
Net income by year
Bottom line
| Fiscal year | BQ | POM |
|---|---|---|
| FY2025 | CNY -5.1M | CNY -130.9M |
| FY2024 | CNY -54.1M | CNY -37.4M |
| FY2023 | CNY -63.7M | CNY -36.9M |
More in this industry